The parenteral GLP-1 receptor agonist market is projected to grow by $47,567 million, the GLP-1 receptor agonists for hospitals market by $43,598 million, and the semaglutide-based GLP-1 receptor agonist market by $38,238 million over the next five years from 2025 to 2030
LanHHoosLMLiuLTetzloffGHuWAbbondanzoSJet al
GLP-1, or glucagon-like peptide-1, is a hormone that plays a crucial role in managing blood sugar levels and appetite
99.9% purity means the peptide makes up nearly all of the measured content, based on laboratory analysis methods used in peptide production
Glutathione helps treat and manage symptoms such as alcoholism, glaucoma, AIDS, and fatty liver disease
Understanding the whole patient prior to receiving transplant and cellular therapy: Real-world data on patients financial toxicity prior to receiving treatment Miranda Kapfhammer 1 , Rachel Cusatis 1 , Deborah Mattila 2 , Sarah Smith 2 1 Medical College of Wisconsin, Milwaukee, USA, 2 National Marrow Donor Program (NMDP), Minneapolis, USA Aims Cellular therapy (CT) recipients are at high risk for financial toxicity (FT) given the frequent need for temporary re-location, loss of income for patients and caregivers in addition to the expected medical expenses of cancer care
